Navigation Links
Prof. Dr. George Gettinby Honored With Dieter Lutticken Award
Date:5/19/2008

BOXMEER, Netherlands, May 19 /PRNewswire/ -- At the "World Aquaculture 2008", held on May 19-23 in Busan, Korea, Prof. Dr. George Gettinby from the University of Strathclyde, Scotland, United Kingdom, was honored with the Intervet Dieter Lutticken Award for his innovative statistical and epidemiological research methods in sea-lice treatments in salmon farming. The jury found his research methods an excellent example of commitment to the advancement of reducing, refining and replacing the use of animals in research, development and production of veterinary medicines.

Prof. Dr. George Gettinby's research focused on the application of statistical and epidemiological methods in sea-lice treatments in salmon farming in order to minimize the number of animals required in test groups. Gettinby's research also provides an alternative to assessing the effectiveness of veterinary medicines in fish, which supports the replacement principle. This alternative is the adoption of mathematical models which can simulate the effects of treatments on lice populations.

Dr. Dieter Lutticken, who presented the award, with a prize fund of 20,000 Euro said: "There has been a long and intimate relationship between life sciences and statistics. Prof. Gettinby's innovative statistical and epidemiological research methods are an excellent example of refining and reducing the use of animals in sea-lice treatments in salmon farming. I am pleased that we can honor Prof. Gettinby at the World Aquaculture Conference today."

The panel of jury experts praised "Prof. Dr. Gettingby's innovating mathematical model approach for investigating the optimal use of treatments and one which involves minimal use of animals. In addition, these methods also minimize the use of veterinary medicines in the environment."

Prof. Gettinby said: "I am honored to receive the Dieter Lutticken Award and it is pleasing to know that the Award has come as a result of the increasing role of statistics and mathematical modelling in the pursuit of medicines for animals and the improved health of species in aquaculture. In accepting this award, I gratefully acknowledge the collaboration, support and work of the Marine Harvest Ltd, Scottish Quality Salmon, the UK Department for Environment, Food and Rural Affairs and the Epi-informatics research group at the University of Strathclyde."

The Dieter Lutticken award, established in 2004, aims to encourage research into the use of alternative models for animal testing with significant impact on the development or production of new animal health products. Intervet/Schering-Plough Animal Health welcomes submissions from scientists and public life-science institutions. The euro 20,000 award is named after Dr. Dieter Lutticken, a committed researcher in microbiology and virology. He guided and shaped Intervet's R&D for more than a quarter of a century. Dr. Lutticken retired in 2003 from his position as Vice President and Head of R&D.

The award's scope covers in vitro models used in R&D which replace animal testing for licensing purposes as well as studies avoiding the use of animals in efficacy, safety and quality testing in the production of biologicals and pharmaceuticals for animals.

A jury panel composed of experts from public institutions of the animal health/animal testing sector and Intervet representatives looks for possible candidates and makes the final selection. Intervet also welcomes submissions from all life-science research institutions. Commercial organizations are excluded. For more information on applications, please contact Global Communications, Animal Health, Boxmeer, The Netherlands (communications@intervet.com). This year's deadline is November 15, 2008.

Note for the editor

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its website is http://www.schering-plough.com.

For more information about Intervet/Schering-Plough Animal Health visit the following website: http://www.intervet.com http://www.spah.com


'/>"/>
SOURCE Schering-Plough
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ready: UH prof. chronicles phenomenon of new later motherhood
2. AlphaMed Press Names George Kendall Vice President, Operations and Business Development
3. Georgetown researchers find stem cell marker controls 2 key cancer pathways
4. George Institute receives Gates Foundation grant to survey funding flows
5. Georgetown U student selected for prestigious Bouchet Society
6. Home Oxygen Community Applauds Senator George Voinovich for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
7. American Tailgaters Association, ESPNs Sean Salisbury and George Foreman Unite in the Fight Against Pediatric Cancers Around Super Bowl XLII
8. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
9. Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team
10. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
11. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 ... the "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural ... Structural electronics involves electronic and/or ... protective structures, replacing dumb structures such as vehicle ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
Breaking Medicine Technology: